Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Galia Rahav and Oliver Cornely.
Galia Rahav
Connection Strength
1.010
Oliver Cornely
  1. Isavuconazole for treatment of rare invasive fungal diseases. Mycoses. 2018 Aug; 61(8):518-533.
    View in: PubMed
    Score: 0.779
  2. Effect and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial. Infect Dis Ther. 2018 Dec; 7(4):439-455.
    View in: PubMed
    Score: 0.049
  3. Treatment outcomes in patients with proven/probable vs possible invasive mould disease in a phase III trial comparing isavuconazole vs voriconazole. Mycoses. 2018 Nov; 61(11):868-876.
    View in: PubMed
    Score: 0.049
  4. Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal species. Mycoses. 2018 Jul; 61(7):485-497.
    View in: PubMed
    Score: 0.048
  5. Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection. N Engl J Med. 2017 01 26; 376(4):305-317.
    View in: PubMed
    Score: 0.044
  6. Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis. Lancet Infect Dis. 2016 Jul; 16(7):828-837.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.